|
NCCN Tumor Boards: Optimizing Clinical Decision-Making for Resectable Non-Small Cell Lung Cancer |
1.00 |
02/13/2026 - 12:00am to 07/26/2026 - 12:00am |
|
NCCN Optimizing Patient Outcomes - Hepatocellular Carcinoma: Latest Systemic Therapy Recommendations |
1.00 |
02/27/2026 - 12:00am to 08/16/2026 - 11:59pm |
|
Archived NCCN Tumor Boards: Optimizing Treatment of Chronic Phase Chronic Myeloid Leukemia |
1.00 |
03/09/2026 - 12:00am to 02/24/2027 - 11:59pm |
|
NCCN Optimizing Patient Outcomes - From Mutation to Treatment: Understanding the Impact of New Targeted Therapies in Central Nervous System Cancers |
1.00 |
04/01/2026 - 12:00am to 09/11/2026 - 11:59pm |
|
NCCN Guidelines® Insights - Merkel Cell Carcinoma, Version 1.2024 (JA copy) |
1.00 |
04/01/2026 - 12:00am to 12/31/2026 - 11:59pm |
|
NCCN Optimizing Patient Outcomes - Hitting the Right Target: Updates in Biomarker-Directed Therapy for Non-Small Cell Lung Cancer |
1.00 |
04/09/2026 - 12:00am to 10/04/2026 - 11:59pm |
|
NCCN Optimizing Patient Outcomes - Recent Advancements in Chemoradiation Strategies for Locally Advanced Cervical Cancer |
1.00 |
04/13/2026 - 12:00am to 08/30/2026 - 11:59pm |
|
Archived NCCN Tumor Boards: New and Emerging Systemic Therapy Options in Bladder Cancer |
1.00 |
09/05/2025 - 12:00am to 08/24/2026 - 11:59pm |
|
Recorded Presentation from Optimizing Patient Outcomes - Metastatic Castration-Resistant Prostate Cancer: Systemic Therapy Updates |
1.00 |
05/02/2025 - 12:00am to 05/02/2026 - 12:00am |
|
Archived NCCN Tumor Boards: T-Cell Engager Therapy for Diffuse Large B-Cell Lymphoma: Bispecific Antibodies for Relapsed/Refractory Disease |
1.00 |
05/06/2025 - 12:00am to 04/30/2026 - 12:00am |
|
NCCN Guidelines® Insights - Multiple Myeloma, Version 1.2025 |
1.00 |
05/10/2025 - 12:00am to 05/10/2026 - 12:00am |
|
Recorded Presentation from Optimizing Patient Outcomes - Targeted Therapies for Thyroid Carcinoma |
1.00 |
05/27/2025 - 12:00am to 05/27/2026 - 12:00am |
|
Archived NCCN Tumor Boards: New Approaches to the Management of Resectable Non-Small Cell Lung Cancer |
1.00 |
05/28/2025 - 12:00am to 05/22/2026 - 11:59pm |
|
Archived NCCN Tumor Boards: Treatment Options and Navigating Sequencing of Therapies in Relapsed/Refractory Multiple Myeloma |
1.00 |
05/28/2025 - 12:00am to 05/23/2026 - 11:59pm |
|
NCCN Guidelines® Insights - Survivorship, Version 2.2025 |
1.00 |
06/10/2025 - 12:00am to 06/10/2026 - 12:00am |
Facebook
X
LinkedIn
Forward